In search of synergy in scientific research 

On 30 September this year, the scientists from three universities in Gdañsk being the members of the Daniel Fahrenheit Association of Universities met to present their research and to think over the possibilities of cooperation. The meeting was attended by the Coordinators of Priority Research Areas of GUMed - Prof. Jacek Jassem, Prof. Krzysztof Narkiewicz and Prof. Ryszard Tomasz Smoleński. The Gdańsk University of Technology and the University of Gdańsk were represented by representatives of a total of nine research areas (such as medical technology; biotechnology, biomedical and molecular research; theoretical research on quantum technologies; cross-cultural research; environmental research and technology).
The meeting was organized by Prof. Tomasz Bączek, plenipotentiary of the Rector for the IDUB Programme and Leader of the Team for defining areas of synergy in scientific research in the process of consolidation of Gdańsk universities.

Support of the “Excellence Initiative – Research University” Program for experienced researchers 

At the beginning of September this year, the results of the first grant competition addressed to experienced researchers at GUMed, i.e. persons who hold a postdoctoral degree or a professor title were published. The competition aims to support researchers, especially in the implementation of projects leading to external funding or publication of research results in the most prestigious journals. 
61 projects with a total value of nearly PLN 3.5 million were submitted to the competition. 24 of them were selected for funding. A pool of nearly PLN 1.4 million has been allocated for their support, 70% of which was financed from the IDUB Program Office. The next edition of the competition is planned for spring 2022. For more information, please click here.
Partners wanted

The Medical University of Rostock is seeking entities interested in forming partnerships for selected calls under Horizon Europe within the Health cluster (Pillar 2):
Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers, HORIZON-HLTH-2022-TOOL-11-01
Personalised blueprint of chronic inflammation in health-to-disease transition, HORIZON-HLTH-2022-STAYHLTH-02
If you are interested, please contact the Project Office (
Supporting Structures 

In 2021, as part of the implementation of the Excellence Initiative Program - Research University, a network of support structures was established. How have we helped researchers?

Excellence of Scientific Publications Unit

We funded 24 publications from the first decile and quartile for more than 179 thousand PLN with IDUB program funds.
We have made 22 language corrections.
We provided graphic support to 12 Author(s).

Centre of Biostatistics and Bioinformatics Analysis

We have provided 83 free consultations (72 biostatistical, 9 bioinformatics, 2 on artificial intelligence). 
We assisted in 8 grant applications, writing 5 scientific manuscripts and 1 thesis.
We have completed 6 large biostatistical analyses and 3 large bioinformatic analyses (we are in the process of 3 more biostatistical and 2 bioinformatic analyses).
And in addition. we are involved in the Academy of Grants, Micro-Grants initiative, we are creating a simulation game within the "Science is people" project.
We invite you to cooperate with us!

Open grant competitions
NAWA's Urgency Grants program for international collaborations of research teams or international mobility of researchers that are undertaken in response to sudden, important, unforeseen social, civilizational, and natural phenomena with global or regionally significant consequences.
Past events 


A workshop of Team 10 Molecular and biochemical methods for study mechanisms of civilization diseases, which is part of the Priority Research Area Biochemistry, Genetics, Molecular Biology, was held on September 22. 

The next three parts of the meeting were devoted to discussing the status of research activities of the teams led by Prof. Rafał Bartoszewski from the Department of Biology and Pharmaceutical Botany, Prof. Katarzyna Zorena from the Division of Immunobiology and Environmental Microbiology, and Dr. Habil. Barbara Kutryb-Zając representing the Department of Biochemistry. The meeting was held in the hybrid formula, attended by nearly 100 people. 


Recently, several meetings were also held within the Oncology Priority Research Area (basket coordinators meeting, basket 4, and basket 8 meeting).
Upcoming events

In vivo research at the MUG - let's get to know each other! 
20.10.2021, 12:30-14.00 (on Clickmeeting platform)

Plan of the meeting:
- Prof. Ryszard Tomasz Smoleński - The role of in vivo research in the development of medicine and science,
- Vet. Grażyna Peszyńska-Sularz - Tri-City Academic Animal Experimental Station as a place where science and business can meet and exchange human and "non-human" experiences,
- Marta Tomczyk, Ph.D. - "Mousing" in the pathophysiology of cardiovascular diseases. Research models available in the Department of Biochemistry,
- Ryszard Milczarek, Ph.D. - Legal aspects of (co)working with animals,
- Dr. Habil. Patrycja Koszałka - The use of GMO and GMM in scientific research.
Coordinators of the V PRA 3 team cordially invite you! If you are interested, please register using the form.
training for those planning to participate in animal experimentation (Teams platform and CBiV centers)

The training is organized by the Faculty of Biology of the University of Gdańsk, and completion of such training is by law a condition for participation in experiments using live animals. The training is open to students, Ph.D. students, and employees of the MUG.
More information and application forms are available at www.
The week with clusters in Horizon Europe FP. Cluster 1 Health 
18.10.2021, 10.00-13.00 hours 

The webinar will discuss the competitions for 2022 (opening on 6 October 2021) and the topics identified by the EC in the area of health. Pre-registration necessary at www.
Recommended publications

Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group, Boyer Olivia; Schaefer Franz; Haffner Dieter; Bockenhauer Detlef; Hölttä Tuula; Bérody Sandra; Webb Hazel; Heselden Marie; LIPSKA-ZIĘTKIEWICZ BEATA; Ozaltin Fatih; Levtchenko Elena; Vivarelli Marina, Nature reviews. Nephrology, vol. 17 (4) 2021, 277-289. 

Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls, Darras B. T.; Masson R.; MAZURKIEWICZ-BEŁDZIŃSKA MARIA; Rose K.; Xiong H.; Zanoteli E.; Baranello G.; Bruno C.; Vlodavets D.; Wang Y.; El-Khairi M.; Gerber M.; Gorni K.; Khwaja O.; Kletzl H.; Scalco R. S.; Fontoura P.; Servais L., New England Journal of Medicine, vol. 385 (5), 427-435.

Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer, Tutt A.N.J.; Garber J.E.; Kaufman B.; Viale G.; Fumagalli D.; Rastogi P.; Gelber R.D.; de Azambuja E.; Fielding A.; Balmana J.; Domchek S.M.; Gelmon K.A.; Hollingsworth S.J.; Korde L.A.; Linderholm B.; Bandos H.; SENKUS-KONEFKA ELŻBIETA; Suga J.M.; Shao Z.; Pippas A.W.; Nowecki Z.; Huzarski T.; Ganz P.A.; Lucas P.C. ; Baker N.; Loibl S.; McConnell R.; Piccart M.; Schmutzler R.; Steger G.G.; Costantino J.P.; Arahmani A.; Wolmark N.; McFadden E.; Karantza V.; Lakhani S.R.; Yothers G.; Campbell C.; Geyer, Jr. C.E., New England Journal of Medicine. vol. 384 (25), 2394-2405.
Copyright © Medical University of Gdańsk, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.